Yoken's disease (Hypersensitivity pneumonitis) - Symptoms, Causes, Treatment & Prevention

```html

Overview

Yoken’s disease is the historical name given to hypersensitivity pneumonitis (HP), an immune‑mediated inflammation of the lung tissue that occurs after repeated inhalation of a wide variety of environmental antigens. The condition is sometimes called “extrinsic allergic alveolitis.”

Who it affects

• Adults aged 20‑60 years are most commonly diagnosed, but children and the elderly can be affected.
• People with occupational or hobby‑related exposure to organic dusts (e.g., farmers, bird‑keepers, textile workers) have the highest risk.
• Both sexes are affected; some registries show a slight female predominance when exposure is related to domestic bird keeping.

Prevalence

• In the United States, HP accounts for roughly 1–2 % of interstitial lung diseases, translating to an estimated 10 – 15 cases per 100,000 population annually (CDC, 2022).
• Higher rates are reported in rural agricultural regions and in countries where indoor heating with biomass fuels is common.

Symptoms

The presentation can be acute, sub‑acute, or chronic, depending on the intensity and duration of antigen exposure.

Acute (hours to days after exposure)

• Fever and chills – often mistaken for a viral infection.
• Dry cough – non‑productive, may be harsh.
• Shortness of breath – usually mild to moderate, worsening with activity.
• Chest tightness or pain – pleuritic quality.
• Fatigue, malaise, and muscle aches.

Sub‑Acute (weeks to months of repeated exposure)

• Persistent dry cough.
• Progressive dyspnea on exertion.
• Low‑grade fever (often absent).
• Weight loss and loss of appetite.
• Occasional wheezing.

Chronic (months to years of ongoing exposure)

• End‑stage breathlessness, even at rest.
• Dry, hacking cough that may become productive with sputum.
• Clubbing of the fingers (in advanced cases).
• Chest discomfort or “tightness.”
• Signs of right‑heart strain (e.g., peripheral edema) if pulmonary hypertension develops.

Causes and Risk Factors

HP results from an abnormal immune response—mainly a type III (immune‑complex) and type IV (delayed‑type) hypersensitivity reaction—to inhaled antigens. The offending agents are classified into three broad groups:

1. Thermophilic actinomycetes (moldy hay, grain, compost)

Common in farmers, mushroom growers, and workers handling stored grain (“farmer’s lung”).

2. Bird proteins and droppings

Exposure to parrots, pigeons, chickens, or swine (often called “bird‑fancier’s lung”).

3. Other organic or inorganic particles

• Fungal spores from indoor molds.
• Mycobacteria from “hot‑tub lung.”
• Chemical vapors (e.g., isocyanates, metal dusts) – less common but documented.

Risk Factors

• Occupational exposure: farming, woodworking, textile manufacturing, metal casting, bakery work.
• Domestic exposure: keeping pet birds, indoor pigeon lofts, houseplants with mold.
• Genetic predisposition: HLA‑DR alleles (e.g., HLA‑DRB1*1301) have been linked to higher susceptibility.
• Pre‑existing lung disease (asthma, COPD) may amplify the inflammatory response.
• Smoking does not protect against HP and may worsen outcomes.

Diagnosis

Diagnosing HP is challenging because symptoms overlap with asthma, COPD, and other interstitial lung diseases. A systematic approach that combines exposure history, imaging, lung function testing, and sometimes biopsy is recommended.

1. Detailed exposure questionnaire

Clinicians ask about occupation, hobbies, home environment, recent travel, and any known mold or bird exposures.

2. Pulmonary function tests (PFTs)

• Restrictive pattern: Decreased total lung capacity (TLC) and forced vital capacity (FVC).
• Reduced diffusion capacity (DLCO): Often the earliest abnormality.
• In acute cases, a mixed obstructive‑restrictive picture may be seen.

3. Chest imaging

• High‑resolution CT (HRCT): Ground‑glass opacities, centrilobular nodules, and mosaic attenuation are characteristic. Chronic disease shows fibrosis, traction bronchiectasis, and honey‑comb changes.
• Chest X‑ray: May be normal early on; later shows diffuse reticulonodular pattern.

4. Laboratory testing

• Elevated serum precipitating antibodies (IgG) to suspected antigens—a supportive, not definitive, finding.
• Complete blood count may reveal mild leukocytosis or eosinophilia.

5. Bronchoalveolar lavage (BAL)

Fluid shows a lymphocytosis >20 % (often 40‑50 %) in HP, helping to differentiate from other interstitial lung diseases.

6. Lung biopsy (when needed)

Transbronchial or surgical (VATS) biopsy can demonstrate poorly formed granulomas, interstitial infiltrates, and bronchiolitis. Biopsy is reserved for atypical cases.

Diagnostic Algorithms

Guidelines from the American Thoracic Society (ATS) and European Respiratory Society (ERS) recommend a “probability” approach: low, intermediate, or high likelihood based on the combination of exposure history, HRCT, BAL, and serology (Wilkinson et al., 2020).

Treatment Options

Therapy aims at removing the offending antigen, suppressing the inflammatory response, and preserving lung function.

1. Antigen avoidance

• Eliminate or drastically reduce exposure (e.g., relocate bird lofts, use protective masks, improve ventilation).
• Environmental remediation—professional mold remediation for contaminated homes.

2. Pharmacologic therapy

• Corticosteroids (e.g., prednisone 0.5‑1 mg/kg/day) are the first‑line treatment for acute and sub‑acute disease. Taper over weeks to months based on clinical response.
• Steroid‑sparing agents – azathioprine, mycophenolate mofetil, or methotrexate may be used in chronic HP when long‑term steroids are undesirable.
• Antifibrotic agents (nintedanib, pirfenidone) have shown benefit in progressive fibrotic HP in recent trials (King et al., 2022, *Lancet Respir Med*).

3. Pulmonary rehabilitation

Exercise training, breathing techniques, and education improve functional capacity and quality of life, especially in chronic disease.

4. Supplemental oxygen

Prescribed when resting SpO₂ < 88 % or exertional desaturation; improves activity tolerance and reduces pulmonary hypertension risk.

5. Advanced interventions

• Lung transplantation is considered for end‑stage fibrotic HP refractory to medical therapy.
• Management of complications (e.g., pulmonary hypertension with endothelin‑receptor antagonists) follows standard guidelines.

Living with Yoken’s Disease (Hypersensitivity Pneumonitis)

Adapting daily life can help control symptoms and slow disease progression.

Practical Tips

• Environmental control: Use HEPA air purifiers, dehumidifiers (< 60 % RH), and keep indoor humidity low to prevent mold growth.
• Protective equipment: When unavoidable exposure exists (e.g., farming), wear N‑95 or higher respirators and change clothes/shower immediately after work.
• Vaccinations: Stay up‑to‑date on influenza, pneumococcal (PCV20 or PCV15 + PPSV23), and COVID‑19 vaccines to reduce respiratory infection risk.
• Medication adherence: Take steroids exactly as prescribed; never stop abruptly to avoid adrenal insufficiency.
• Monitor symptoms: Keep a diary of cough, breathlessness, and exposure events; discuss changes with your provider promptly.
• Exercise: Low‑impact activities (walking, stationary biking, swimming) 3‑5 times per week improve endurance without overtaxing the lungs.
• Nutrition: A balanced diet rich in antioxidants (fruits, vegetables) supports immune health. In chronic disease, adequate protein helps maintain muscle mass.
• Psychosocial support: Join support groups for interstitial lung disease; consider counseling to cope with chronic illness stress.

Prevention

Because HP is triggered by inhaled antigens, primary prevention focuses on exposure control.

• Occupational safety: Follow OSHA or local regulations for ventilation, dust suppression, and respiratory protection in at‑risk industries.
• Home maintenance: Fix water leaks, clean or discard mold‑infested items, and avoid indoor bird cages in poorly ventilated rooms.
• Hygiene practices: Shower and change clothes before entering living areas after work in dusty environments.
• Personal protective equipment (PPE): Use properly fitted N‑95 respirators when handling hay, grain, or bird droppings.
• Education: Awareness programs for farmers, pet store workers, and hobbyists about HP risk increase early detection and avoidance.

Complications

If exposure continues or disease is not adequately treated, chronic inflammation can lead to irreversible lung damage.

• Fibrotic remodeling: Progressive scarring causing permanent loss of lung elasticity.
• Pulmonary hypertension: Elevated pressure in pulmonary arteries adds strain to the right heart.
• Cor pulmonale: Right‑ventricular failure due to long‑standing pulmonary hypertension.
• Respiratory failure: Severe hypoxemia requiring long‑term oxygen or mechanical ventilation.
• Increased susceptibility to infections: Steroid use and damaged lung architecture raise pneumonia risk.
• Reduced quality of life and functional capacity: Activities of daily living become limited, affecting independence.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, National Institutes of Health (NIH), American Thoracic Society/European Respiratory Society guidelines, Lancet Respiratory Medicine (2022), *Journal of Allergy and Clinical Immunology* (2021), WHO occupational health factsheets.

```